OOIR: Observatory of International Research

Papers

(The median citation count of European Neuropsychopharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	131
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	97
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	79
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	79
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	79
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	76
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	73
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	60
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	59
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	57
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	57
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	56
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	55
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	53
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	47
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	46
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION	45
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	45
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE	43
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	43
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	41
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	41
Society Calendar	40
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	39
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	39

W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	39
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	39
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY	38
DECOLONISATION OF PSYCHIATRIC GENETICS: PERSPECTIVES FROM AN ERSTWHILE “JEWEL IN THE CROWN” COLONY	36
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	36
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	34
THE ASSOCIATION BETWEEN POLYGENIC RISK FOR SCHIZOPHRENIA AND BRAIN AGE IN A POPULATION-BASED SAMPLE OF YOUNG ADULTS: A RECALL-BY-GENOTYPE-BASED APPROACH	34
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	31
DO POOR DIET AND LIFESTYLE BEHAVIOURS EXACERBATE THE GENETIC RISK OF IMPULSIVITY IN THE GENERAL POPULATION	30
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT	30
T121. MULTI-OMIC NETWORK ANALYSIS IDENTIFIES KEY NEUROBIOLOGICAL PATHWAYS IN OPIOID ADDICTION	29
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT	28
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	28
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD	27
T70. A COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC PAIN	27
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA	27
Norepinephrine system dysconnectivity in major depressive disorder: the effect of short term SSRI treatment	26
ECNP Calendar of Meetings	26
Editorial Board	26
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES	26
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder	25
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats	25
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	24
Muscle and the mind: The combination of creatine and exercise for depression	23
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	23
Are cell type-specific methylation profiles the missing link in ADHD epigenetics?	23
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	23
M70. INTRODUCTION TO THE MOUNT SINAI MILLION SCHIZOPHRENIA DISCOVERIES PROGRAM (MSM-SCZ)	22
T39. POLYGENIC RISK AND CHILDHOOD TRAUMA AS PREDICTORS OF SUICIDE RISK IN BIPOLAR DISORDER	22
BEYOND STANDARD GWAS IN BIPOLAR DISORDER: INTEGRATIVE FINE-MAPPING, MULTI-TRAIT, AND EPIGENETIC APPROACHES FOR CAUSAL VARIANT DISCOVERY	22
M74. RE-EVALUATING THE ROLE OF 22Q11 DELETION SYNDROME (22Q11DS) IN SCHIZOPHRENIA	21
W87. PREDICTORS OF ALCOHOL CONSUMPTION: THE ROLE OF GENETICS AND IMPULSIVITY FROM ADOLESCENCE TO ADULTHOOD	21
ELECTRONIC HEALTH RECORDS AND BIOBANKS IN THE ERA OF COMPUTATIONAL AND GENOMIC PSYCHIATRY	21
W2. MULTIVARIABLE GENE ENVIRONMENT INTERACTION IN THE PREDICTION OF PROSOCIAL BEHAVIOR	21
T33. MULTI-OMICS MACHINE LEARNING APPROACHES TO ELUCIDATE BIOLOGICAL SIGNATURES OF DEPRESSION: INSIGHTS FROM THE UK BIOBANK	21
W17. CONCORDANT AND DISCORDANT GENETIC VARIANTS ASSOCIATED WITH MENTAL ILL-HEALTH AND THEIR IMPACT ON CARDIOMETABOLIC RISK	20
3. MODELING AGE-DEPENDENT GENETIC EFFECTS ON TEMPERAMENT AND MENTAL HEALTH	20
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder	19
The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders	19
W47. THE GENETIC ARCHITECTURE OF DIFFICULT-TO-TREAT DEPRESSION: A PHARMLINES INITIATIVE COHORT STUDY	19
Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls	19
87. ATLAS OF PHENOTYPE-GENOTYPE RELATIONSHIPS BETWEEN PLASMA METABOLIC MARKERS, BRAIN MORPHOLOGY AND PSYCHIATRIC DISORDERS	19
17. LANDSCAPE SURVEY OF 8853 CLINICAL TRIALS IN DEPRESSION TO IDENTIFY NEW TREATMENT RESPONSE PHARMACOGENETIC STUDIES	19
T8. TREATMENT WITH GALANTAMINE IN 15Q13.3 DELETIONS: GENOMICALLY-INFORMED PRECISION MEDICINE STRATEGIES IN NEURODEVELOPMENTAL DISORDERS	18
Editorial Board	18
Stress, mental disorder and ketamine as a novel, rapid acting treatment	18
W38. INVESTIGATION OF GENE-ENVIRONMENT INTERACTIONS BETWEEN GENETICALLY REGULATED GLUCOCORTICOID REACTIVITY AND STRESSFUL LIFE EVENTS IN MAJOR DEPRESSIVE DISORDER	17
W31. KETAMINE AND ELECTROCONVULSIVE THERAPY DEPRESSION TREATMENTS ALTER ISOFORM- AND CELL TYPE-SPECIFIC TRANSCRIPTOMES IN THE MOUSE PREFRONTAL FRONTAL CORTEX	17
Editorial Board	17
T75. ASSOCIATIONS BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND SCHIZOTYPAL TRAITS IN THE MULTIPLEX FAMILIES OF PATIENTS WITH SCHIZOPHRENIA	16

F10. TRACES OF ASSORTATIVE MATING FOR MENTAL DISORDERS IN THE HUMAN GENOME	16
LONGITUDINAL GENETIC APPROACHES IN MENTAL HEALTH: INTERNATIONAL PERSPECTIVES AND OPPORTUNITIES	16
T71. GENETIC AND ENVIRONMENTAL ASSOCIATION BETWEEN PRESENT MOMENT ATTENTION AND SUBJECTIVE WELLBEING	16
W17. REGIONAL GENETIC ARCHITECTURE OF THE CORPUS CALLOSUM AND ITS OVERLAP WITH PSYCHIATRIC AND SUBSTANCE USE PHENOTYPES	16
INNOVATING KNOWLEDGE DISSEMINATION FOR CULTURAL RELEVANCE AND ACCESSIBILITY	16
T3. DEPRESSION ASSOCIATED GENETIC, TRANSCRIPTOMIC AND PATHWAY -LEVEL PROFILING OF TRAUMA-EXPOSED MILITARY AND CIVILIAN COHORTS	16
F99. GENETIC CORRELATION OF CHILDHOOD AGGRESSION WITH MENTAL AND GENERAL HEALTH TRAITS	16
ABSENCE OF NONFATAL SUICIDAL BEHAVIOR PRECEDING SUICIDE DEATH REVEALS CLINICAL AND GENETIC RISK DIFFERENCES	16
F59. DISENTANGLING THE OVERLAP BETWEEN SUICIDE ATTEMPT AND ASSOCIATED PHENOTYPES USING LOCAL GENETIC CORRELATIONS	16
75. GWAS IDENTIFIES NOVEL LOCI ASSOCIATED WITH SPECIFIERS OF BIPOLAR DISORDER	15
W9. IDENTIFYING CENTRAL AND TRANS-DIAGNOSTIC PSYCHIATRIC SYMPTOMS COMBINING NETWORK ANALYSIS AND GENETICS	15
20. PHENOME-WIDE ASSOCIATION STUDY OF COGNITIVE FUNCTION IN MULTIETHNIC ASIAN POPULATION	15
87. RS148582811 REGULATES ITS HOST GENE ARVCF EXPRESSION TO AFFECT NICOTINE-ASSOCIATED HIPPOCAMPUS-DEPENDENT MEMORY	15
W32. A GENOME-WIDE ASSOCIATION STUDY OF BIPOLAR DISORDER FROM INDIA	15
46. PATHWAY-BASED POLYGENIC RISK SCORES USING MACHINE LEARNING: APPLICATION TO SCHIZOPHRENIA AND BIPOLAR DISORDER	14
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDIES PROVIDE NOVEL BIOLOGICAL INSIGHTS INTO THE GENETIC ARCHITECTURE OF BIPOLAR DISORDER	14
T68. DDR1 PROMOTER METHYLATION IN DIFFERENT PSYCHIATRIC DISORDERS AND ITS RELATIONSHIP TO NEUTROPHIL-TO-LYMPHOCYTE RATIOS	14
Prader Willi syndrome, its psychiatric implications and their possible biological basis	14
A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood	14
54. EXAMINING COMMON AND SPECIFIC GENETIC INFLUENCES ON SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION	14
PRESENTING A MULTIDISCIPLINARY FRAMEWORK FOR RESEARCH GENOME SEQUENCING COUPLED WITH GENETIC COUNSELING AND RETURN OF CLINICALLY VALIDATED PRIMARY AND SECONDARY FINDINGS FOR INDIVIDUALS WITH PSYCHIATR	14
DECODING CELL TYPE-SPECIFICITY THROUGH SYSTEMATIC CELL TYPE ANNOTATIONS OF SINGLE-CELL RNA SEQUENCING DATA AMONG TISSUES AND APPLICATION TO PSYCHIATRIC DISORDERS AND OTHER TRAITS	14
Cell type-specific methylome-wide association studies of childhood ADHD symptoms	14
WHOLE EXOME SEQUENCING IN AN AUTISM MULTIPLEX FAMILY OF INDIAN ORIGIN REVEALS INCREASED GENETIC BURDEN OF MATERNALLY TRANSMITTED VARIANTS	14
PRS PREDICTION BEYOND FAMILY HISTORY	14
TREML2 IN THE CONTEXT OF WHITE MATTER HYPERINTENSITIES AND ALZHEIMER'S DISEASE	14
Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)	14
Social Stress in Bipolar Disorder	14
EXOME SEQUENCING TECHNOLOGY AND ANALYSIS	13
F93. CELL-TYPE SPECIFIC TRANSCRIPTOMIC PROFILING IN SCHIZOPHRENIA IDENTIFIES CHANGES IN GABAERGIC NEURONS AND OLIGODENDROCYTES AT TRANSCRIPT LEVEL	13
GENOMIC STRUCTURAL EQUATION MODELING APPLIED TO 14 MAJOR PSYCHIATRIC DISORDERS	13
Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?	13
ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER	13
T23. ASSOCIATION OF CHILDHOOD TRAUMA EXPOSURE WITH DDR1 PROMOTER METHYLATION IN BIPOLAR DISORDER	13
Letter to the editor concerning: “Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis”	13
F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES	13
POLYGENIC SCORE OF POST-TRAUMATIC STRESS DISORDER HIGHLIGHTS ASSOCIATION WITH CARDIOVASCULAR DISORDERS IN ELECTRONIC HEALTH RECORDS OF >94,000 INDIVIDUALS	13
73. IMPACT OF GENETIC RISK VARIANTS OF MENTAL DISORDERS ON EPIGENETIC REGULATION: AN MQTL APPROACH	12
W14. EXPLORING THE RELATIONSHIP BETWEEN GENETIC PREDISPOSITION TO MENTAL HEALTH DISORDERS AND THE SOCIAL ENVIRONMENT IN THE UK BIOBANK	12
32. PRINCIPAL AND INDEPENDENT GENOMIC COMPONENTS OF BRAIN STRUCTURE AND FUNCTION: ROBUSTNESS AND RELEVANCE	12
W6. INTERACTION BETWEEN BDNF METHYLATION, SUICIDAL IDEATION, AND LONG-TERM OUTCOMES AFTER STROKE	12
T65. GENES IN POSTMORTEM BRAIN TISSUE DIFFERENTIALLY EXPRESSED IN CHRONIC PAIN	12
ECNP Calendar of Meetings	12
Serotonin 5-HT2A receptors in schizophrenia: Reflexions on an unfinished story	12
W97. A GENOMEWIDE ASSOCIATION STUDY OF ANTIPSYCHOTIC INDUCED EXTRAPYRAMIDAL SIDE EFFECTS	12
W35. INVESTIGATION OF RELATIONSHIPS BETWEEN INTERNALIZING, EXTERNALIZING, AND RISKY SEXUAL BEHAVIOR: A GENETICALLY-INFORMATIVE SAMPLE	12
86. AN INTERNATIONAL, CASE-CASE MEGA-ANALYSIS OF TREATMENT-RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	12
T95. ITERATING TOWARDS PRECISION PHENOTYPING OF SCHIZOPHRENIA IN THE ELECTRONIC HEALTH RECORD	12
PHARMACOGENETICS OF ANXIETY AND OBSESSIVE-COMPULSIVE DISORDERS	11
SLEEP INERTIA DRIVES THE ASSOCIATION OF EVENING CHRONOTYPE WITH PSYCHIATRIC DISORDERS: GENETIC AND EPIDEMIOLOGICAL EVIDENCE	11
W44. UNVEILING GENETIC ARCHITECTURES FOR STRATIFYING TRAJECTORIES OF ADOLESCENT DEPRESSION	11
W54. DETECTION OF DIFFERENTIALLY EXPRESSED GENES IN IPSC-DERIVED TROPHOBLAST CULTURES FROM CONTROLS AND PATIENTS WITH SCHIZOPHRENIA	11
W88. GENETICALLY FASTER CYP2A6-MEDIATED NICOTINE METABOLISM INCREASES SMOKING-RELATED DISEASE RISK: A PHENOME-WIDE ASSOCIATION STUDY IN THE ALL OF US RESEARCH PROGRAM	11
M25. POLYGENIC RISKS AND CARDIOVASCULAR TREATMENT EFFECTS IN SEVERE MENTAL ILLNESS	11
EVALUATING THE CAUSAL RELATIONSHIP BETWEEN EDUCATIONAL ATTAINMENT AND MENTAL HEALTH	11
M45. OPEN BOARD	11
W1. CAN RESPONSE TO PSYCHOTHERAPY IN OBSESSIVE-COMPULSIVE DISORDER BE PREDICTED FROM DNA METHYLATION DATA?	11
INSIGHTS INTO THE METABOLIC ORIGINS OF ANOREXIA NERVOSA THROUGH GENOMICS AND NEUROIMAGING	11
16. HOW DO PATIENTS WITH MAJOR DEPRESSION RESPOND TO DOSAGE INCREMENTS OF ANTIDEPRESSANTS? A CLINICAL AND GENETIC INVESTIGATION IN UK BIOBANK	11
As in cooking, so in medicine: Doses do matter	11
Pediatric Bipolar Disorder – Misinformation with Unintended Negative Consequences for Children and Adolescents	11
W12. BIDIRECTIONAL CROSS-TRAIT GENETIC NURTURE BETWEEN INTERNALIZING AND SUBSTANCE USE DOMAINS	11
AN INTERNATIONAL, CASE-CASE META-ANALYSIS OF TREATMENT RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	11
POPULATION MEDICAL GENOMICS IN LATIN AMERICA	11
M21. POLYGENICITY OF ANOREXIA NERVOSA AT THE PATHWAY LEVEL	11
F11. PATTERNS OF GENETIC OVERLAP BETWEEN BIPOLAR DISORDER, SUBSTANCE USE DISORDERS AND SUBSTANCE CONSUMPTION PHENOTYPES REVEAL DISTINCT FACTORS OF PATHOLOGY	10
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence	10
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years	10
W66. NEUROBIOLOGICAL CORRELATES OF MALE SEXUAL ORIENTATION	10
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.	10
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD coh	10
Number needed to treat and number needed to harm: What are they good for?	10
Biomarker innovations in precision psychiatry diagnostics and treatment strategies	10
T62. EXPLORING THE LANDSCAPE OF GENETIC TESTING FOR AUTISM: PERSPECTIVES FROM AUTISTIC INDIVIDUALS, FAMILIES, AND PHYSICIANS AND TRENDS IN HEALTHCARE DATA IN ALBERTA, CANADA	10
BEYOND BORDERS: INTEGRATING TRAINING AND RESEARCH FOR SCIENTIFIC EXCELLENCE AND GLOBAL EQUITY	10
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	10
Associations between individual depressive symptoms and immunometabolic characteristics in major depression	10
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trial	10
THE ROLE OF SEX IN POLYGENIC RISK FOR SEX-BIASED BRAIN DISORDERS	10
Antidepressant use in pregnancy and neonatal outcomes: reassuring findings from an asian cohort	10

41. USING BRAIN CELL-TYPE-SPECIFIC INTERACTOMES OF PROTEINS ENCODED BY RISK GENES TO UNCOVER BIOLOGY UNDERLYING SCHIZOPHRENIA AND RELATED DISORDERS	9
HOW DO WE MAKE POLYGENIC RISK SCORES (PRS) UNDERSTANDABLE? THE DEVELOPMENT AND EVALUATION OF A NEW TOOL TO ACCOMPANY PRS	9
T28. EXPLORING THE RELATIONSHIP BETWEEN ACNE AND MENTAL HEALTH DISORDERS	9
T54. FIRST GWAS ON AFFECTIVE TEMPERAMENTS IDENTIFIES NOVEL GENOME-WIDE SIGNIFICANT VARIANT FOR ANXIOUS TEMPERAMENT AND SUGGESTIVE VARIANTS FOR ALL FIVE AFFECTIVE TEMPERAMENTS	9
AN ONTOLOGICAL BASED APPROACH TO CHARACTERIZE THE BEHAVIORAL DIFFERENCES BETWEEN PATIENTS WITH 16P11.2 DUPLICATION AND DELETION	9
THE IMPACT OF EARLY ADVERSITY AND EDUCATIONAL ATTAINMENT ON GENETIC AND BRAIN MORPHOLOGICAL PREDICTORS OF INTELLIGENCE	9
F39. CONTRIBUTION OF COMMON POLYGENIC VARIATION TO THERAPY RESPONSE IN THE EARLY MEDICATION CHANGE COHORT	9
13. DISTINGUISHING DIFFERENT PSYCHIATRIC DISORDERS USING DDX-PRS	9
The genetics of treatment-resistant depression: controversies and perspectives	9
Exploring the incidence of inadequate response to antidepressants in the primary care of depression	9
GENOME-WIDE GENE-GENE INTERACTION OF THE 5-HTTLPR PROMOTER POLYMORPHISM EMPHASIZES THE IMPORTANT ROLE OF NEUROPLASTICITY IN DEPRESSION	9
CONTRIBUTION OF GENOME SEQUENCING IN THE EVALUATION OF CHILDREN AND ADOLESCENTS WITH SUSPECTED SERONEGATIVE AUTOIMMUNE ENCEPHALITIS	9
MERGING THE BOUNDARIES BETWEEN THE BRAIN AND THE HEART: UNDERSTANDING THE SHARED BIOLOGY OF MOOD DISORDERS AND CARDIO-METABOLIC PHENOTYPES USING GENETICS, GENOMICS AND ELECTRONIC HEALTH RECORD DATA	9
F44. DIFFERENCES IN POLYGENIC RISK SCORE FOR MAJOR DEPRESSIVE DISORDER DEPENDING ON CASE DEFINITION IN AN ELECTRONIC HEALTH RECORDS STUDY	9
GENOME-WIDE ASSOCIATION STUDIES OF ANOREXIA NERVOSA: AN OVERVIEW, UPDATE, AND IMPLICATIONS	9
94. AN INDUCED PLURIPOTENT STEM CELL (IPSC) RESOURCE FROM GENETICALLY ISOLATED FAMILIES WITH NEUROPSYCHIATRIC DISORDERS	9
PERCEPTIONS OF CAUSAL ATTRIBUTION AND ATTITUDES TO GENETIC TESTING AMONG PEOPLE WITH SCHIZOPHRENIA AND THEIR FIRST-DEGREE RELATIVES	9
T85. INVESTIGATING THE GENETIC ARCHITECTURE OF REGIONAL BRAIN STRUCTURE AND ITS RELATIONSHIP TO SCHIZOPHRENIA	9
CHARACTERIZING THE LOCAL GENETIC CORRELATIONS BETWEEN 14 MAJOR PSYCHIATRIC DISORDERS	9
F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS	9
F59. DISSECTING THE CONTRIBUTIONS OF RARE AND COMMON GENETIC VARIATION TO NEURODEVELOPMENTAL OUTCOMES	9
26. UNRAVELING THE HETEROGENEITY OF PTSD SYMPTOMS THROUGH IDENTIFYING EPIGENETIC SUBTYPES AMONG TRAUMA-EXPOSED CIVILIAN WOMEN	8
THE GENETIC ARCHITECTURE OF BEAT SYNCHRONIZATION THROUGH A NEURODEVELOPMENTAL AND NEURO-FUNCTIONAL LENS	8
W23. GENOME-WIDE ASSOCIATION STUDY OF UNCONTROLLED EATING	8
WHOLE GENOME SEQUENCING	8
I WOULDN'T TREAT A [POLYGENIC RISK] SCORE WITH PILLS	8
EXPANDING OUR UNDERSTANDING OF GENETIC RISK FOR BINGE EATING VIA A GENOME-WIDE ASSOCIATION STUDY	8
F73. CLINICAL AND GENETIC TRAUMA-RELATED RISK FACTORS LEADING TO SUICIDE DEATH	8
57. TRANSCRIPTOMIC DYSFUNCTION DISPARITIES: GREATER BURDEN IN FEMALE BRAINS HIGHLIGHTS IMMUNE AND SYNAPTIC PATHWAYS FOR PSYCHIATRIC DISORDERS	8
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases	8
PRELIMINARY RESULTS FROM THE FIRST SPANISH GWAS ON DEPRESSION IN THE EPIDEMIOLOGICAL PISMA-EP STUDY.	8
Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data	8
INTEGRATING POLYGENIC RISK SCORES WITHIN TWIN MODELLING TO INVESTIGATE THE CAUSAL RISK FACTORS FOR SELF-HARM	8
W85. EVALUATION OF THE PSYCHOMETRIC PROPERTIES OF THE UBACC QUESTIONNAIRE IN ASSESSING CAPACITY TO CONSENT IN DIVERSE AFRICAN POPULATIONS	8
T82. ASSOCIATION OF SCHIZOPHRENIA POLYGENIC RISK SCORES WITH TREATMENT-RESISTANT SCHIZOPHRENIA	8
Assessing risk for bipolar disorder. Comments on ``Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study'' (Martin	8
IMMUNO-PSYCHIATRY AND INFLAMMATION	8
How else can inflammation kill you?	8
VARIANCE QUANTITATIVE TRAIT LOCI MAPPING IN THE MOBA COHORT: DETECTING INTERACTION EFFECTS INVOLVED IN DEVELOPMENTAL OUTCOMES	8
Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis	8
T4. SHARED GENETIC RISK FACTORS CONTRIBUTE TO THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PREGNANCY AND MENTAL HEALTH CONDITIONS	7
T86. GENOME-WIDE ASSOCIATION STUDY OF IRRITABILITY FOLLOWING SMOKING CESSATION IN A CLINICAL TRIAL	7
MODELING MATERNAL INFLAMMATION AND NEURODEVELOPMENT-RELEVANT ENDPOINTS IN BRAIN ORGANOIDS	7
MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF PTSD, ALCOHOL USE AND ALCOHOL USE DISORDERS	7
PRELIMINARY INVESTIGATIONS INTO THE GUT MICROBIOME'S ROLE IN SCHIZOPHRENIA	7
62. INVESTIGATING THE FAMILIAL CO-AGGREGATION OF PSYCHIATRIC, SOMATIC, AND BEHAVIORAL OUTCOMES WITH BORDERLINE PERSONALITY DISORDER IN A SWEDISH BIRTH COHORT: SHARED GENETIC OR ENVIRONMENTAL FACTORS?	7
T91. IL-3RA (RS 6603272 G/T) GENE POLYMORPHISM IN THE BATAKNESE POPULATION WITH SCHIZOPHRENIA AND ITS CORRELATION TO NEGATIVE SYMPTOMS	7
W71. LONGITUDINAL BIOPSYCHOSOCIAL MARKERS OF POSTTRAUMATIC OUTCOMES IN A DIVERSE GROUP OF EMERGENCY RESPONDERS	7
REMOVING PLEIOTROPIC SIGNALS REVEAL DISEASE-SPECIFIC GENETIC ARCHITECTURE IN NOISY, SHALLOW BIOBANK PHENOTYPES	7
METHODS FOR UNDERSTANDING GENETIC CONTRIBUTIONS TO LIFECOURSE MENTAL DISORDERS	7
RARE CODING VARIANTS IN 195,257 INDIVIDUALS REVEAL 29 NOVEL BIPOLAR DISORDER GENES AND STRUCTURAL MISSENSE HOTSPOTS IN PROTEIN SPACE	7
33. GENETIC REGULATION OF HUMAN BRAIN RNA EDITING IN EAST ASIAN	7
83. CHARACTERIZING BIOPSYCHOSOCIAL FACTORS AND RELATIONSHIPS WITH CLINICAL TRAITS FOR PSYCHOTIC-LIKE EXPERIENCES IN ADOLESCENTS	7
SHARED CARDIOVASCULAR RISK FACTORS AND GENETIC OVERLAP OF POSTPARTUM DEPRESSION AND MAJOR DEPRESSIVE DISORDER	7
FUNCTIONAL GENOMIC APPROACHES WITH SINGLE-CELL RESOLUTION PROVIDE MECHANISTIC AND BIOLOGICAL INSIGHTS BASED ON GENETIC ASSOCIATION STUDIES	7
51. GENETIC NURTURE EFFECTS IN DEPRESSIVE AND ANXIETY DISORDERS AND SYMPTOMS, AND IN RELATED TRAITS	7
66. INTEGRATED SINGLE-CELL MULTIOMIC PROFILING OF CAUDATE NUCLEUS SUGGESTS KEY MECHANISMS IN ALCOHOL USE DISORDER	7
COMBINING GENETIC AND NEUROIMAGING RISK SCORES FOR THE PREDICTION OF PSYCHIATRIC DISORDERS	7
T37. GENOME-WIDE ASSOCIATION STUDY (GWAS) OF ANTIDEPRESSANT TREATMENT RESPONSE IN MAJOR DEPRESSIVE DISORDER IN JAPANESE POPULATION	7
75. MIR1255A REGULATES PATHWAYS CRITICAL FOR BRAIN DEVELOPMENT, RISK GENES FOR DEPRESSION AND NEURODEVELOPMENTAL DISORDERS	7
W76. CONFIRMATORY FACTOR ANALYSES OF PSYCHOSIS SYMPTOMS EXHIBIT MEASUREMENT NONINVARIANCE ACROSS CLINICAL PHASE OF ILLNESS IN SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER, AND BIPOLAR I DISORDER	7
T72. RISK LOCI ASSOCIATED WITH INTERNET GAMING DISORDER IN ADOLESCENT: A GENOME-WIDE ASSOCIATION STUDY	7
F52. DNA METHYLATION AT BIRTH AS POTENTIAL MEDIATOR BETWEEN PARENTAL FACTORS AND CHILD ATTENTION DEFICIT HYPERACTIVITY DISORDER – A GENETICALLY INFORMED PROSPECTIVE COHORT STUDY	7
CURRENT CHALLENGES AND OPPORTUNITIES IN DATA-DRIVEN APPROACHES IN NEUROPSYCHIATRIC DISORDERS	7
T60. GENETIC CORRELATES OF AGE AT AUTISM DIAGNOSIS IS ASSOCIATED WITH VARYING MENTAL HEALTH AND DEVELOPMENTAL PROFILES, AND HETEROGENEITY IN AUTISM	7
JOINT MULTI-FAMILY HISTORY AND MULTI-POLYGENIC SCORE PREDICTION OF MAJOR DEPRESSIVE DISORDER	6
Response to the letter regarding “Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach”	6
Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study	6
T56. NEONATAL BLOOD TRANSCRIPTOMICS REVEAL EXPRESSION SIGNATURES OF ADHD RISK	6
The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses	6
NEURONAL-SPECIFIC METHYLOME AND HYDROXYMETHYLOME ANALYSIS IDENTIFIES NOVEL LOCI ASSOCIATED WITH ALCOHOL USE DISORDER	6
SYSTEMS BIOLOGY OF PTSD REVEALS MECHANISMS OF RISK AND DISEASE PROCESSES AT BRAIN MULTI-OMIC, BRAIN CELL TYPE, AND BLOOD LEVELS	6
Immuno-psychiatry: Dreams or reality?	6
Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker	6
PHARMACOGENETIC INFORMED PRESCRIBING FOR MAJOR DEPRESSIVE DISORDER	6
FINE-MAPPING ACROSS DIVERSE ANCESTRIES DRIVES THE DISCOVERY OF PUTATIVE CAUSAL VARIANTS UNDERLYING HUMAN COMPLEX TRAITS AND DISEASES	6
Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens	6
CONTRIBUTION OF POLYGENIC SCORES FOR A “COMMON EXECUTIVE FUNCTION” FACTOR TO COGNITIVE PERFORMANCE IN THE PSYCOURSE STUDY	6
W91. FAMILY BASED GENOME-WIDE ASSOCIATION ANALYSIS OF NOVELTY SEEKING IN A KOREAN SCHIZOPHRENIC POPULATION: A PILOT STUDY	6
Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)	6
Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice	6
F57. INVESTIGATION OF THE SEX CHROMOSOMES IN AUTISM SPECTRUM DISORDER	6
Disease continuum centered on Parkinson's disease	6
Traumatic loss, bereavement, and prolonged grief disorder in times of war: insights from Ukraine	6
W98. GENETIC ARCHITECTURE AND POLYGENIC PREDICTION OF ALCOHOL USE DISORDER IN NEPAL	6
11. GENETIC EPIDEMIOLOGY AND POLYGENICITY OF PSYCHOTIC MAJOR DEPRESSIVE DISORDER	6
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance	6
M3. INVESTIGATING RISK VARIANTS OF THE SLC6A15 GENE BY USE OF ENHANCER SCREENING ASSAY AND CELLULAR MODELS	5
42. SHARED GENETIC VARIANTS BETWEEN OBJECTIVELY-MEASURED MOVEMENT AND BRAIN DISORDERS PROBE SENSORIMOTOR MECHANISMS	5
Editorial Board	5
HUMAN GENOMICS BRAZILIAN INITIATIVES AND THE PROJECT GENOMAS-SUS	5
71. ESTABLISHING THE RELATIONSHIP BETWEEN BRAIN STRUCTURE AND CELLULAR SENESCENCE	5
7. GENOME-WIDE ASSOCIATION STUDIES OF SUICIDAL THOUGHTS AND BEHAVIORS: AN UPDATE FROM THE PSYCHIATRIC GENOMICS CONSORTIUM SUICIDE WORKING GROUP	5
SEX DIFFERENCES IN THE CONFOUNDERS INFLUENCING THE RELATIONSHIPS LINKING SOCIOECONOMIC FACTORS AND COGNITIVE PERFORMANCE WITH FAMILY HISTORY OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS	5
PRECISION PHENOTYPING OF MAJOR DEPRESSIVE DISORDER: LEVERAGING DEEP LEARNING FOR ENHANCED GENETIC DISCOVERY	5